Misbah Tahir
Förmögenhet: - $ per 2026-07-31
Förmögenhet: - $ per 2026-07-31
Misbah Tahir is currently Chief Financial & Accounting Officer at Maze Therapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at IGM Biosciences, Inc. from 2019 to 2025.
Previously, was Vice President & Head-Finance at Dermira, Inc. from 2014 to 2018.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Stephen M.
Ross School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 2026-03-31 | 0 ( -.--% ) | - $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Finansdirektör/CFO | 2025-09-02 |
| Företag | Position | Slut |
|---|---|---|
| IGM BIOSCIENCES, INC. | Finansdirektör/CFO | 2025-08-01 |
| DERMIRA, INC. | Företagsledare/Principal | 2018-12-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
IGM Biosciences, Inc.
IGM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops engineered IgM antibodies for the treatment of cancer patients | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån